Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Total Debt (2018 - 2025)

Rockwell Medical (RMTI) has disclosed Total Debt for 10 consecutive years, with $10.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Debt fell 1.6% year-over-year to $10.5 million, compared with a TTM value of $10.5 million through Sep 2025, down 1.6%, and an annual FY2024 reading of $10.8 million, changed 0.46% over the prior year.
  • Total Debt was $10.5 million for Q3 2025 at Rockwell Medical, up from $8.6 million in the prior quarter.
  • Across five years, Total Debt topped out at $21.2 million in Q1 2021 and bottomed at $5.8 million in Q3 2023.
  • Average Total Debt over 5 years is $12.7 million, with a median of $10.8 million recorded in 2024.
  • The sharpest move saw Total Debt plummeted 63.27% in 2022, then skyrocketed 82.76% in 2024.
  • Year by year, Total Debt stood at $20.6 million in 2021, then tumbled by 63.27% to $7.6 million in 2022, then soared by 42.86% to $10.8 million in 2023, then rose by 0.46% to $10.8 million in 2024, then decreased by 3.28% to $10.5 million in 2025.
  • Business Quant data shows Total Debt for RMTI at $10.5 million in Q3 2025, $8.6 million in Q2 2025, and $11.0 million in Q1 2025.